Stories
SCHOTT Poonawalla Starts Work on $400 Million India IPO
M
Moneycontrol•21-10-2026, 14:50
SCHOTT Poonawalla Starts Work on $400 Million India IPO
- •SCHOTT Poonawalla has initiated preliminary steps for a domestic initial public offering aiming to raise around $400 million.
- •The Mumbai-based pharmaceutical packaging provider has invited investment banks to pitch for the proposed IPO.
- •The company is backed by Germany's SCHOTT Pharma and private equity firm TPG Growth, with Serum Institute of India as a minority investor.
- •The proposed issue is expected to comprise a combination of fresh shares and an offer for sale, potentially allowing stakeholders to dilute part of their stake.
Key Questions Answered
SCHOTT Poonawalla has initiated preliminary steps for an initial public offering with the intent to raise around $400 million, though the final issue size and valuation remain subject to change based on market conditions.
Germany-based SCHOTT Pharma holds a 50% stake in SCHOTT Poonawalla, while private equity firm TPG Growth holds a 35% stake.
SCHOTT Poonawalla produces primary packaging solutions including prefillable syringes for biologic drugs, cartridges for auto-injector pens, vials, and ampoules.
